Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROMAN: Ranolazine vs Amlodipine in CAD
NCT01490255Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in coronary artery disease (CAD), sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
ranolazine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01490255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490255.